Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up
暂无分享,去创建一个
L. Douw | M. Taphoorn | J. Reijneveld | J. Heimans | W. Vandertop | N. Aaronson | B. Slotman | T. Postma | J. Sluimer | M. Klein | R. Boerman | G. Beute | R. H. Boerman | Selene Saa Fagel | J. V. D. Heuvel | Jacob J Mooij | Josje van den Heuvel | J. J. Mooij | Ben J. Slotman | Neil K. Aaronson | Selene S A A Fagel | Peter Vandertop | Rudolf H Boerman | N. K. Aaronson
[1] Susan M. Chang,et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Lauren E. Abrey,et al. Longitudinal cognitive follow-up in low grade gliomas , 2008, Journal of Neuro-Oncology.
[3] E. Aronica,et al. Cerebral necrosis after 25Gy radiotherapy in childhood followed 28 years later by 54Gy radiotherapy , 2007, Clinical Neurology and Neurosurgery.
[4] D. Correa,et al. Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] P. Box. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial , 2006 .
[6] E. Shaw,et al. Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. , 2005, International journal of radiation oncology, biology, physics.
[7] Martin Klein,et al. Epilepsy in low‐grade gliomas: The impact on cognitive function and quality of life , 2003, Annals of neurology.
[8] B. Scheithauer,et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] E. Shaw,et al. Prospective clinical trials of intracranial low-grade glioma in adults and children. , 2003, Neuro-oncology.
[10] M. Castillo,et al. A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors , 2003, Neurology.
[11] A. Kaye,et al. Low grade glial neoplasms , 2003, Journal of Clinical Neuroscience.
[12] R. Riccardi,et al. Long‐term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia , 2002, Cancer.
[13] J. Jolles,et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study , 2002, The Lancet.
[14] P. Scheltens,et al. Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma , 2002, Neurology.
[15] J. Hunter,et al. Late cognitive and radiographic changes related to radiotherapy: Initial prospective findings , 2002, Neurology.
[16] A. Karim,et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Philippe Cornu,et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. , 2002, International journal of radiation oncology, biology, physics.
[18] A. Paetau,et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients , 2001, Neurology.
[19] M. Taphoorn,et al. Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas , 2001, Neurology.
[20] J. Jolles,et al. Pesticide exposure and risk of mild cognitive dysfunction , 2000, The Lancet.
[21] L. Deangelis,et al. Long-term outcome of low-grade oligodendroglioma and mixed glioma , 2000, Neurology.
[22] J. Delattre,et al. Neurological complications of radiotherapy and chemotherapy , 1998, Journal of Neurology.
[23] J. Jolles,et al. [The Maastricht aging study (MAAS). The longitudinal perspective of cognitive aging]. , 1998, Tijdschrift voor gerontologie en geriatrie.
[24] J. Delattre,et al. A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. , 1996, International journal of radiation oncology, biology, physics.
[25] L. Recht,et al. Low-grade gliomas. , 1995, Neurologic clinics.
[26] A. Karim,et al. Cognitive functions and quality of life in patients with low‐grade gliomas: The impact of radiotherapy , 1994, Annals of neurology.
[27] E. Neuwelt,et al. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] J Rosenman,et al. Future directions in 3-dimensional radiation treatment planning. , 1993, Oncology.
[29] B. Scheithauer,et al. Management of supratentorial low-grade gliomas. , 1991, Oncology.
[30] K. Wallner,et al. Good performance status of long-term disease-free survivors of intracranial gliomas. , 1993, International journal of radiation oncology, biology, physics.
[31] L. Recht,et al. Suspected low‐grade glioma: Is deferring treatment safe? , 1992, Annals of neurology.
[32] S. Piantadosi,et al. Low‐grade cerebral astrocytomas: Survival and quality of life after radiation therapy , 1990, Cancer.
[33] L. Deangelis,et al. Radiation‐induced dementia in patients cured of brain metastases , 1989, Neurology.
[34] S Ekholm,et al. Adverse effects of brain irradiation correlated with MR and CT imaging. , 1987, International journal of radiation oncology, biology, physics.
[35] D. Wade,et al. The Barthel ADL Index: a standard measure of physical disability? , 1988, International disability studies.
[36] A. Alavi,et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.
[37] D. Karnofsky,et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .